PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity
Joseph E. Saavedra(Genesis Laboratories), Larry K. Keefer(Unknown), Thomas Wilde(Frederick National Laboratory for Cancer Research), Gregory S. Buzard, Matthew E. Cuellar(University of Minnesota), Jeffrey R. Deschamps(United States Naval Research Laboratory), Keiko Inami(Frederick National Laboratory for Cancer Research), David J. Waterhouse, Kenneth D. Tew(Medical University of South Carolina), Xinhua Ji(Frederick National Laboratory for Cancer Research), Victoria J. Findlay(Virginia Commonwealth University), Michael L. Citro(Genesis Laboratories), Aloka Srinivasan(Frederick National Laboratory for Cancer Research), Lee Jia(Henan University), Paul J. Shami(University of Utah), Damon A. Parrish(United States Naval Research Laboratory), Danyelle M. Townsend(Medical University of South Carolina), Keith M. Davies(George Mason University), Shivendra V. Singh(UPMC Hillman Cancer Center)
Cited by 92
Related Papers
Blood Flow Regulation by <i>S</i> -Nitrosohemoglobin in the Physiological Oxygen Gradient
|Science|1997|1.1k
“NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
|Methods in enzymology on CD-ROM/Methods in enzymology|1996|674
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655